Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACROBAT Evolve: Paltusotine in Acromegaly
NCT03792555Phase 2Completed
- Sponsor
- Crinetics Pharmaceuticals
- Start
- Mar 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 2, randomised, double-blind trial in acromegaly comparing Paltusotine with Placebo (2 arms). Primary endpoint: Proportion of Responders at 13 weeks. Started Mar 2019; status: completed.
02
Drugs
paltusotine
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT03792555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03792555.